Literature DB >> 6251245

Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells.

A K Cheung, M D Hoggan, W W Hauswirth, K I Berns.   

Abstract

A clone of human cells (Detroit 6) latently infected by adeno-associated virus (AAV) has been characterized with regard to the status of the viral DNA. In both early (9 to 10) and late (118) passages of the clone, AAV-DNA was recombined with host DNA, at least in some cases as a head-to-tail tandem repeat, via the terminal sequences of the viral genome. However, it was not possible to distinguish between integration into chromosomal DNA and very large plasmids (< 20 x 10(6) molecular weight) which contain both viral and cellular DNA sequences. Although evidence for some modifications of the viral sequence was obtained, most of the integrated sequences appeared to be intact. In some cases sequences of undetermined origin separated adjacent copies of the viral genome. Free copies of the AAV genome were detectable in late passage cells, but not in early passage cells. The orientation of nucleotide sequences present in the free AAV DNA from late passage cells was indistinguishable from that of virion DNA. With the notable exception, the organization of the integrated AAV sequences as determined by restriction enzyme digestion remained constant with continued passage. Digestion with SmaI, which cleaves within the palindromic region of the terminal repetition in AAV DNA, produced reproducibly different patterns when early and late passage DNAs were compared. Several models for rescue of free copies of the genome from the integrated DNA are possible, all of which involve the terminal repetition.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6251245      PMCID: PMC288599     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Adeno-associated virus autointerference.

Authors:  B J Carter; C A Laughlin; L M de la Maza; M Myers
Journal:  Virology       Date:  1979-01-30       Impact factor: 3.616

2.  Establishment and characterization of KB cell lines latently infected with adeno-associated virus type 1.

Authors:  H Handa; K Shiroki; H Shimojo
Journal:  Virology       Date:  1977-10-01       Impact factor: 3.616

3.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

4.  Origin and termination of adeno-associated virus DNA replication.

Authors:  W W Hauswirth; K I Berns
Journal:  Virology       Date:  1977-05-15       Impact factor: 3.616

5.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

6.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

7.  Enzymatic synthesis of deoxyribonucleic acid. XXXII. Replication of duplex deoxyribonucleic acid by polymerase at a single strand break.

Authors:  R B Kelly; N R Cozzarelli; M P Deutscher; I R Lehman; A Kornberg
Journal:  J Biol Chem       Date:  1970-01-10       Impact factor: 5.157

8.  Inhibition of adenovirus 12 oncogenicity by adeno-associated virus.

Authors:  R L Kirschstein; K O Smith; E A Peters
Journal:  Proc Soc Exp Biol Med       Date:  1968-07

9.  A membrane-filter technique for the detection of complementary DNA.

Authors:  D T Denhardt
Journal:  Biochem Biophys Res Commun       Date:  1966-06-13       Impact factor: 3.575

10.  Concatemers of alternating plus and minus strands are intermediates in adenovirus-associated virus DNA synthesis.

Authors:  S E Straus; E D Sebring; J A Rose
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

View more
  98 in total

1.  Kinetics of recombinant adeno-associated virus-mediated gene transfer.

Authors:  A K Malik; P E Monahan; D L Allen; B G Chen; R J Samulski; K Kurachi
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo.

Authors:  H Nakai; T A Storm; M A Kay
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

3.  Adeno-associated viruses undergo substantial evolution in primates during natural infections.

Authors:  Guangping Gao; Mauricio R Alvira; Suryanarayan Somanathan; You Lu; Luk H Vandenberghe; John J Rux; Roberto Calcedo; Julio Sanmiguel; Zahra Abbas; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

Review 4.  Parvovirus replication.

Authors:  K I Berns
Journal:  Microbiol Rev       Date:  1990-09

5.  Regulation of adeno-associated virus gene expression in 293 cells: control of mRNA abundance and translation.

Authors:  J P Trempe; B J Carter
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

6.  Adenovirus E1B 55-Mr polypeptide facilitates timely cytoplasmic accumulation of adeno-associated virus mRNAs.

Authors:  R J Samulski; T Shenk
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

7.  AAV2 X increases AAV6 rep/cap-driven rAAV production.

Authors:  M Cao; M Chiriva-Internati; P L Hermonat
Journal:  Virology       Date:  2015-03-30       Impact factor: 3.616

8.  Origin of adeno-associated virus DNA replication is a target of carcinogen-inducible DNA amplification.

Authors:  A O Yalkinoglu; H Zentgraf; U Hübscher
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

Review 9.  Viral vectors for gene delivery to the central nervous system.

Authors:  Thomas B Lentz; Steven J Gray; R Jude Samulski
Journal:  Neurobiol Dis       Date:  2011-10-07       Impact factor: 5.996

10.  Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome.

Authors:  C Giraud; E Winocour; K I Berns
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.